Sat, Jul 26, 2014, 12:13 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

VIVUS Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • i_p_day_lee i_p_day_lee Nov 15, 2012 11:36 AM Flag

    stupid longs still think this crap is going up

    Let's put all the bashing and insults aside and just look at the numbers based on Vivus last conference call. They have a very expensive REMS process to fund without a partner. This will burn their cash very quickly. Until they show the finacial community clarity on how Qsymia will generate the revenue required, or they announce a partner (nothing on the horizon there), this will be a very risky investment. Expect a secondary next quarter if they can even pull one off.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, let's look the numbers, 3000 physicians now prescribing Qsymia, 300 million in cash and cash eq. $17 million of the 40 million spent in Q3 was for inventory. Don't expect a secondary anytime soon. Partnership may come at anytime if the price is right for VVUS. Modified REMs in a few months. Direct advertising can start in July 2013.

4.82-0.08(-1.63%)Jul 25 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.